BioGaia
BioGaia is a Swedish healthcare company specializing in the development, marketing, and sale of probiotic products. The company operates through three main segments: the Paediatrics segment, which offers probiotic drops, gut health tablets, oral rehydration solutions, and cultures for use in licensed infant formula; the Adult Health segment, which includes gut health tablets, oral health lozenges, and cultures for licensed dairy products; and an Other segment that generates royalties from development projects and revenue from packaging solutions through its subsidiary CapAble. BioGaia's products aim to improve health across various demographics, with a strong focus on both pediatric and adult consumers. The company operates in multiple regions, enhancing its global presence in the probiotic market.
Top Regions
Top Stages
3 past transactions
Boneprox
Seed Round in 2021
Boneprox AB is a dental healthcare software company based in Gothenburg, Sweden, founded in 2013. The company specializes in developing advanced tools that enhance the efficiency and accuracy of dental diagnostics. Its flagship product, Boneprox, analyzes bone quality and assesses the risk of osteoporosis. Additional offerings include ReferralExpress, which facilitates quick communication between clinics and specialists for referrals, and CBCT-Supervision, designed to streamline the Cone Beam Computed Tomography (CBCT) process in dental practices. Boneprox leverages digital dentistry and advanced imaging technologies to improve the accessibility of specialists and enable healthcare providers to effectively exchange, analyze, and diagnose patient images, ultimately aiming to optimize patient care in dentistry.
MetaboGen
Acquisition in 2018
MetaboGen is a research and development company focused on biomarker and personalized treatment services. It specializes in integrating metagenomic data analysis with clinical programs, aiming to develop innovative therapeutics and next-generation probiotics. The company identifies and enhances bacterial strains related to specific indications, which supports the probiotic industry in creating novel diagnostic tests and treatments. Through its expertise in metagenomics, MetaboGen contributes to advancements in personalized medicine and the development of effective probiotic solutions.
MetaboGen
Corporate Round in 2018
MetaboGen is a research and development company focused on biomarker and personalized treatment services. It specializes in integrating metagenomic data analysis with clinical programs, aiming to develop innovative therapeutics and next-generation probiotics. The company identifies and enhances bacterial strains related to specific indications, which supports the probiotic industry in creating novel diagnostic tests and treatments. Through its expertise in metagenomics, MetaboGen contributes to advancements in personalized medicine and the development of effective probiotic solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.